Dr. Reddy's Laboratories Limited Share Price & Analysis
₹1,283Updated 5 Jun 2026, 03:30 pm IST
LTP
₹1,283
—
Open
₹1,273
High
₹1,289.4
Low
₹1,268.5
Close
₹1,267.5
52W High
₹1,380
52W Low
₹1,148
Volume
775K
Lot Size
625
Sector
Healthcare
Market Cap
₹1.1L Cr
Face Value
₹1
Large CapNIFTY 100NIFTY 200NIFTY 50NIFTY 500
Price Chart
Fundamentals
P/E
25.4
Sector P/E
48.9
P/B
2.83
EPS
₹66.72
ROE
11.8%
ROCE
13.6%
D/E Ratio
0.2
Div Yield
0.63%
Book Value
₹454
+
Strengths
- ✓Attractively valued vs sector (P/E 25.4x vs industry 48.9x)
- ✓Low debt relative to equity (D/E 0.2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| LUPIN Lupin Limited | ₹2,260 | ₹1.0L Cr | 17.9 | 4.6 | 29.1 | 30.3 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
DRREDDY · as of Mar 2026
Promoters26.64%
FII25.75%▼1.10
DII25.63%▲2.74
Public21.69%▼1.77
Others0.29%▲0.13
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 26.65% | 26.65% | 26.65% | 26.64% | 26.64% | 26.64% |
| FII | 28.62% | 29.13% | 27.68% | 27.53% | 26.85% | 25.75% |
| DII | 18.65% | 18.31% | 20.72% | 21.48% | 22.89% | 25.63% |
| Public | 25.89% | 25.73% | 24.78% | 24.20% | 23.46% | 21.69% |
| Others | 0.18% | 0.17% | 0.17% | 0.16% | 0.16% | 0.29% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026
Results11 May 2026
To recommend final dividend, if any, for the Financial year 2025-26
Dividend11 May 2026
To consider and approve the financial results for the quarter and year ending March 31, 2026
Results11 May 2026
Dividend - Rs 8 Per Share
Dividend9 Jul 2025
Face Value Split (Sub-Division) - From Rs 5/- Per Share To Re 1/- Per Share
Split27 Oct 2024
Annual General Meeting/Dividend - Rs 40 Per Share
Dividend15 Jul 2024
Annual General Meeting/Dividend - Rs 40 Per Share
Dividend10 Jul 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹8.8K Cr ▼0.8% | ₹8.8K Cr ▲3.0% | ₹8.6K Cr ▲0.5% | ₹8.5K Cr ▲1.8% | ₹8.4K Cr ▲4.3% | ₹8.0K Cr ▲4.4% | ₹7.7K Cr ▲8.2% | ₹7.1K Cr |
| Op. Profit | ₹1.9K Cr ▼6.1% | ₹2.0K Cr ▼7.5% | ₹2.2K Cr ▲8.8% | ₹2.0K Cr ▼12.1% | ₹2.3K Cr ▲9.5% | ₹2.1K Cr ▼2.5% | ₹2.1K Cr ▲16.3% | ₹1.8K Cr |
| OPM | 22.0% ▼4.3% | 23.0% ▼8.0% | 25.0% ▲8.7% | 23.0% ▼14.8% | 27.0% ▲3.8% | 26.0% ▼7.1% | 28.0% ▲7.7% | 26.0% |
| Net Profit | ₹1.2K Cr ▼11.0% | ₹1.3K Cr ▼5.2% | ₹1.4K Cr ▼11.2% | ₹1.6K Cr ▲13.0% | ₹1.4K Cr ▲4.6% | ₹1.3K Cr ▼3.6% | ₹1.4K Cr ▲6.3% | ₹1.3K Cr |
| EPS (₹) | 14.5 ▼10.2% | 16.14 ▼5.0% | 16.99 ▼11.0% | 19.09 ▲12.7% | 16.94 ▲12.6% | 15.05 ▼9.8% | 16.69 ▲6.3% | 15.7 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹33.7K Cr ▲3.2% | ₹32.6K Cr ▲16.5% | ₹28.0K Cr ▲13.5% | ₹24.7K Cr ▲14.5% | ₹21.5K Cr ▲13.1% | ₹19.0K Cr ▲8.7% | ₹17.5K Cr ▲13.4% | ₹15.4K Cr ▲8.2% | ₹14.3K Cr ▲0.6% | ₹14.2K Cr |
| Expenses | ₹27.2K Cr ▲13.1% | ₹24.1K Cr ▲20.0% | ₹20.1K Cr ▲10.3% | ₹18.2K Cr ▲2.4% | ₹17.8K Cr ▲17.2% | ₹15.2K Cr ▲0.9% | ₹15.0K Cr ▲22.6% | ₹12.3K Cr ▲2.8% | ₹11.9K Cr ▲1.8% | ₹11.7K Cr |
| Op. Profit | ₹6.5K Cr ▼24.5% | ₹8.5K Cr ▲7.7% | ₹7.9K Cr ▲22.6% | ₹6.5K Cr ▲71.7% | ₹3.8K Cr ▼2.7% | ₹3.9K Cr ▲56.4% | ₹2.5K Cr ▼22.1% | ₹3.2K Cr ▲35.2% | ₹2.4K Cr ▼4.9% | ₹2.5K Cr |
| OPM | 19.0% ▼26.9% | 26.0% ▼7.1% | 28.0% ▲7.7% | 26.0% ▲52.9% | 17.0% ▼15.0% | 20.0% ▲42.9% | 14.0% ▼33.3% | 21.0% ▲31.3% | 16.0% ▼5.9% | 17.0% |
| Other Income | ₹1.4K Cr ▲22.6% | ₹1.1K Cr ▲23.1% | ₹909 Cr ▼6.4% | ₹971 Cr ▲75.0% | ₹555 Cr ▲65.7% | ₹335 Cr ▼50.0% | ₹670 Cr ▲75.9% | ₹381 Cr ▲145.8% | ₹155 Cr ▼9.9% | ₹172 Cr |
| Interest | ₹374 Cr ▲32.2% | ₹283 Cr ▲65.5% | ₹171 Cr ▲19.6% | ₹143 Cr ▲49.0% | ₹96 Cr ▼1.0% | ₹97 Cr ▼1.0% | ₹98 Cr ▲10.1% | ₹89 Cr ▲12.7% | ₹79 Cr ▲25.4% | ₹63 Cr |
| Depreciation | ₹2.1K Cr ▲20.8% | ₹1.7K Cr ▲15.9% | ₹1.5K Cr ▲17.6% | ₹1.3K Cr ▲7.3% | ₹1.2K Cr ▼5.2% | ₹1.2K Cr ▲5.7% | ₹1.2K Cr ▲2.5% | ₹1.1K Cr ▲5.4% | ₹1.1K Cr ▲4.9% | ₹1.0K Cr |
| PBT | ₹5.4K Cr ▼29.8% | ₹7.7K Cr ▲6.7% | ₹7.2K Cr ▲19.1% | ₹6.0K Cr ▲97.6% | ₹3.1K Cr ▲6.1% | ₹2.9K Cr ▲52.9% | ₹1.9K Cr ▼19.3% | ₹2.3K Cr ▲73.0% | ₹1.4K Cr ▼13.1% | ₹1.6K Cr |
| Tax % | 23.0% ▼8.0% | 25.0% ▲8.7% | 23.0% ▼8.0% | 25.0% ▼13.8% | 29.0% ▼9.4% | 32.0% ▲557.1% | -7.0% ▼141.2% | 17.0% ▼46.9% | 32.0% ▲68.4% | 19.0% |
| Net Profit | ₹4.2K Cr ▼27.4% | ₹5.7K Cr ▲2.6% | ₹5.6K Cr ▲23.8% | ₹4.5K Cr ▲106.6% | ₹2.2K Cr ▲11.8% | ₹2.0K Cr ▼3.7% | ₹2.0K Cr ▲3.9% | ₹1.9K Cr ▲105.9% | ₹947 Cr ▼26.7% | ₹1.3K Cr |
| EPS (₹) | 50.27 ▼25.8% | 67.77 ▲1.3% | 66.87 ▲23.5% | 54.14 ▲106.4% | 26.23 ▲11.8% | 23.47 ▼3.7% | 24.38 ▲3.8% | 23.49 ▲105.9% | 11.41 ▼26.8% | 15.59 |
| Div Payout | 16.0% ▲33.3% | 12.0% ▲0.0% | 12.0% ▼20.0% | 15.0% ▼34.8% | 23.0% ▲9.5% | 21.0% ▲0.0% | 21.0% ▲23.5% | 17.0% ▼51.4% | 35.0% ▲34.6% | 26.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹84 Cr ▲1.2% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr ▲0.0% | ₹83 Cr |
| Reserves | ₹35.9K Cr ▲7.4% | ₹33.5K Cr ▲18.8% | ₹28.2K Cr ▲21.4% | ₹23.2K Cr ▲21.3% | ₹19.1K Cr ▲8.9% | ₹17.6K Cr ▲13.2% | ₹15.5K Cr ▲11.3% | ₹13.9K Cr ▲11.6% | ₹12.5K Cr ▲2.5% | ₹12.2K Cr |
| Borrowings | ₹5.9K Cr ▲25.2% | ₹4.7K Cr ▲133.6% | ₹2.0K Cr ▲48.6% | ₹1.3K Cr ▼60.2% | ₹3.4K Cr ▲11.6% | ₹3.0K Cr ▲37.1% | ₹2.2K Cr ▼42.4% | ₹3.8K Cr ▼24.3% | ₹5.1K Cr ▲3.1% | ₹4.9K Cr |
| Other Liabilities | ₹12.5K Cr ▲27.6% | ₹9.8K Cr ▲14.9% | ₹8.5K Cr ▲12.5% | ₹7.6K Cr ▲6.0% | ₹7.1K Cr ▲20.9% | ₹5.9K Cr ▲9.3% | ₹5.4K Cr ▲18.8% | ₹4.6K Cr ▼3.2% | ₹4.7K Cr ▲5.2% | ₹4.5K Cr |
| Total Liabilities | ₹54.4K Cr ▲13.2% | ₹48.0K Cr ▲23.8% | ₹38.8K Cr ▲20.4% | ₹32.2K Cr ▲8.3% | ₹29.7K Cr ▲11.9% | ₹26.6K Cr ▲14.5% | ₹23.2K Cr ▲3.6% | ₹22.4K Cr ▲0.3% | ₹22.3K Cr ▲3.2% | ₹21.7K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹20.6K Cr ▲13.1% | ₹18.2K Cr ▲74.8% | ₹10.4K Cr ▲13.1% | ₹9.2K Cr ▲13.5% | ₹8.1K Cr ▼1.0% | ₹8.2K Cr ▲19.8% | ₹6.8K Cr ▼4.7% | ₹7.2K Cr ▲3.2% | ₹7.0K Cr ▲0.5% | ₹6.9K Cr |
| CWIP | ₹2.0K Cr ▼19.0% | ₹2.5K Cr ▲73.8% | ₹1.4K Cr ▲37.8% | ₹1.0K Cr ▼20.3% | ₹1.3K Cr ▼17.4% | ₹1.6K Cr ▲2.0% | ₹1.5K Cr ▼47.7% | ₹2.9K Cr ▼15.4% | ₹3.5K Cr ▲4.4% | ₹3.3K Cr |
| Investments | ₹4.7K Cr ▲16.0% | ₹4.1K Cr ▼17.8% | ₹4.9K Cr ▼1.1% | ₹5.0K Cr ▲90.6% | ₹2.6K Cr ▲18.3% | ₹2.2K Cr ▼17.4% | ₹2.7K Cr ▲3.5% | ₹2.6K Cr ▲12.6% | ₹2.3K Cr ▲8.9% | ₹2.1K Cr |
| Other Assets | ₹27.1K Cr ▲16.2% | ₹23.3K Cr ▲5.8% | ₹22.0K Cr ▲29.6% | ₹17.0K Cr ▼4.2% | ₹17.7K Cr ▲21.3% | ₹14.6K Cr ▲20.1% | ₹12.2K Cr ▲25.3% | ₹9.7K Cr ▲1.0% | ₹9.6K Cr ▲3.5% | ₹9.3K Cr |
| Total Assets | ₹54.4K Cr ▲13.2% | ₹48.0K Cr ▲23.8% | ₹38.8K Cr ▲20.4% | ₹32.2K Cr ▲8.3% | ₹29.7K Cr ▲11.9% | ₹26.6K Cr ▲14.5% | ₹23.2K Cr ▲3.6% | ₹22.4K Cr ▲0.3% | ₹22.3K Cr ▲3.2% | ₹21.7K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹4.6K Cr ▲2.2% | ₹4.5K Cr ▼22.8% | ₹5.9K Cr ▲109.5% | ₹2.8K Cr ▼21.3% | ₹3.6K Cr ▲19.6% | ₹3.0K Cr ▲4.0% | ₹2.9K Cr ▲59.2% | ₹1.8K Cr ▼15.9% | ₹2.1K Cr ▼34.3% | ₹3.3K Cr |
| Investing CF | ₹-5.8K Cr ▼43.4% | ₹-4.0K Cr ▲1.8% | ₹-4.1K Cr ▼60.2% | ₹-2.6K Cr ▼13.7% | ₹-2.3K Cr ▼355.6% | ₹-495 Cr ▲35.6% | ₹-769 Cr ▲48.1% | ₹-1.5K Cr ▲21.5% | ₹-1.9K Cr ▼17.4% | ₹-1.6K Cr |
| Financing CF | ₹1.9K Cr ▲602.9% | ₹-376 Cr ▲86.0% | ₹-2.7K Cr ▼1009.9% | ₹-242 Cr ▼706.7% | ₹-30 Cr ▲98.8% | ₹-2.5K Cr ▼18.0% | ₹-2.1K Cr ▼380.4% | ₹-444 Cr ▼20.3% | ₹-369 Cr ▲78.3% | ₹-1.7K Cr |
| Net Cash Flow | ₹749 Cr ▲463.2% | ₹133 Cr ▲114.7% | ₹-907 Cr ▼30333.3% | ₹3 Cr ▼99.8% | ₹1.3K Cr ▲4863.0% | ₹-27 Cr ▲12.9% | ₹-31 Cr ▲75.0% | ₹-124 Cr ▼8.8% | ₹-114 Cr ▼142.6% | ₹-47 Cr |
| Free Cash Flow | ₹1.3K Cr ▼30.5% | ₹1.9K Cr ▼52.4% | ₹4.0K Cr ▲223.8% | ₹1.2K Cr ▼46.7% | ₹2.3K Cr ▼3.7% | ₹2.4K Cr ▲7.3% | ₹2.2K Cr ▲215.3% | ₹713 Cr ▼23.0% | ₹926 Cr ▼55.2% | ₹2.1K Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 101d ▼3.8% | 105d ▼1.9% | 107d ▼5.3% | 113d ▲18.9% | 95d ▼9.5% | 105d ▲11.7% | 94d ▼9.6% | 104d ▲6.1% | 98d ▲1.0% | 97d |
| Inventory Days | 260d ▼8.1% | 283d ▲22.0% | 232d ▼7.2% | 250d ▼8.4% | 273d ▲18.7% | 230d ▼15.8% | 273d ▲3.8% | 263d ▼6.7% | 282d ▲13.7% | 248d |
| Days Payable | 97d ▼16.4% | 116d ▲7.4% | 108d ▼2.7% | 111d ▲1.8% | 109d ▲9.0% | 100d ▼9.9% | 111d ▼8.3% | 121d ▲16.3% | 104d ▲18.2% | 88d |
| Cash Conv. Cycle | 264d ▼2.6% | 271d ▲17.3% | 231d ▼8.3% | 252d ▼2.7% | 259d ▲10.2% | 235d ▼8.2% | 256d ▲4.1% | 246d ▼10.5% | 275d ▲7.0% | 257d |
| Working Capital Days | 69d ▼41.5% | 118d ▲40.5% | 84d ▲37.7% | 61d ▲7.0% | 57d ▼3.4% | 59d ▼9.2% | 65d ▲66.7% | 39d ▲378.6% | -14d ▼141.2% | 34d |
| ROCE | 23.0% ▼14.8% | 27.0% ▲0.0% | 27.0% ▲92.9% | 14.0% ▼12.5% | 16.0% ▲45.5% | 11.0% ▼15.4% | 13.0% ▲62.5% | 8.0% ▼11.1% | 9.0% ▼52.6% | 19.0% |
Source: Screener.in · Lower days = better efficiency
Deep Dive Analysis
About Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Dr. Reddy's Laboratories Limited share price today?▾
Dr. Reddy's Laboratories Limited (DRREDDY) is currently trading at ₹1,283 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Dr. Reddy's Laboratories Limited available in F&O (Futures & Options)?▾
Yes, Dr. Reddy's Laboratories Limited (DRREDDY) is part of the NSE F&O segment with a lot size of 625 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Dr. Reddy's Laboratories Limited 52-week high and low?▾
Dr. Reddy's Laboratories Limited's 52-week high is ₹1,380 and the 52-week low is ₹1,148. The current price of ₹1,283 is 7.0% below the 52W high.
What is Dr. Reddy's Laboratories Limited P/E ratio?▾
Dr. Reddy's Laboratories Limited's current P/E ratio is 25.4. This indicates the market is paying ₹25.4 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Dr. Reddy's Laboratories Limited options?▾
Dr. Reddy's Laboratories Limited options are traded on NSE with monthly expiry contracts (lot size: 625 shares). To trade DRREDDY options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.